Benchmark Botanics Stock Price To Book

Benchmark Botanics fundamentals help investors to digest information that contributes to Benchmark Botanics' financial success or failures. It also enables traders to predict the movement of Benchmark Pink Sheet. The fundamental analysis module provides a way to measure Benchmark Botanics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Benchmark Botanics pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Benchmark Botanics Company Price To Book Analysis

Benchmark Botanics' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Benchmark Botanics Price To Book

    
  0.88 X  
Most of Benchmark Botanics' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Benchmark Botanics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Benchmark Botanics has a Price To Book of 0.8796 times. This is 96.57% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to book for all United States stocks is 90.75% higher than that of the company.

Benchmark Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Benchmark Botanics' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Benchmark Botanics could also be used in its relative valuation, which is a method of valuing Benchmark Botanics by comparing valuation metrics of similar companies.
Benchmark Botanics is currently under evaluation in price to book category among its peers.

Benchmark Fundamentals

About Benchmark Botanics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Benchmark Botanics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Benchmark Botanics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Benchmark Botanics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Benchmark Pink Sheet

Benchmark Botanics financial ratios help investors to determine whether Benchmark Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Benchmark with respect to the benefits of owning Benchmark Botanics security.